Get premium alternative investment insights

Get the Briefing
EDGAR Verified
Primary Source · SEC.gov

CrowdStreet Life Sciences & Healthcare Fund I, LLC- Series I

CIK 0001916113Fund Vehicle2022 vintage506(c), 3(c)(1)

Raised

$10M

Investors

59

Min Invest

$100,000

AltStreet Analysis

·

Generated from EDGAR primary sources

CrowdStreet Life Sciences & Healthcare Fund I, LLC- Series I is a Delaware pooled investment fund filing under Rule 506(c) and 3(c)(1) exemptions. As of the May 27, 2022 filing, the fund raised $10.3M from 59 accredited investors with a $100K minimum investment. The fund is managed by CrowdStreet Advisors, LLC with Kristen Howell as executive officer.

This real estate fund operates in the life sciences and healthcare property sector with a $100K minimum, positioning it in the mid-tier accredited investor market. The 506(c) exemption allows general solicitation, typical for platform-distributed real estate funds, while the 3(c)(1) exemption limits it to fewer than 100 beneficial owners as a private fund.

Data Flags

sales_commissionsNo sales commissions reported on a $10.3M 506(c) offering with 59 investors, which is unusual for offerings using general solicitation
related_entitiesNo related entities found for CrowdStreet despite platform typically sponsoring multiple offerings

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001916113
Entity NameCrowdStreet Life Sciences & Healthcare Fund I, LLC- Series I
Exemption506(c), 3(c)(1)
First Sale Date
Filing DateMay 27, 2022
Accession Number0001916113-22-000001
Total Amount Sold$10M
Total Investors59
Minimum Investment$100,000
Securities TypePooled Investment Fund
State of IncorporationNot specified
Amendment CountOriginal filing only

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Managing Member CrowdStreet Advisors, LLC

Director · Austin, TX

Kristen Howell

Executive Officer · Austin, TX

Is this your offering?

Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.